It is this foggy aspect of a whispered takeover from one (two would mean "Bidding War!") that I believe explains the long v short battle. (Thanks nat.) One may assume the immediate point is to make money as risk free as possible.
I think it's the medium term that's at play in the short term. Shorting via several brokerages and even more accounts hides significant 5% positions needing to be disclosed. This, if true, then, can springboard into a t/o at the most; key BoD position(s) at worst. With the sp acting accordingly.
Also, and curious to, the shorts (they're down as of 21.1.16, 0.10%,) must pay any divvy to the owner of the borrowed shares. A surprise "Special Dividend" would cause a large short squeeze. This, though, would ruin the short plan and those behind it...
http://shortman.com.au/stock?q=pry
Yesterday I noted a downside risk of 15%, to put a finer point on it: 15% to 20%. That extra bit mostly is assigned by the effects of down outside markets. Clicking "Y" ==================>
shows the damage of many factors, notably shorts, and the worst they can do. Now click "M" =======>
With an initial position bought I'm looking for a bit of panic to BUY.
OV
- Forums
- ASX - By Stock
- HLS
- Back to $3.50 by July?
Back to $3.50 by July?, page-12
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLS (ASX) to my watchlist
|
|||||
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $1.063B |
Open | High | Low | Value | Volume |
$1.49 | $1.50 | $1.46 | $1.339M | 908.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 14378 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 915 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 14378 | 1.460 |
2 | 9840 | 1.455 |
1 | 6105 | 1.450 |
4 | 20819 | 1.445 |
4 | 77822 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 915 | 1 |
1.470 | 52192 | 2 |
1.475 | 31189 | 3 |
1.480 | 20939 | 4 |
1.485 | 10211 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
HLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online